Inovio Biomedical Corporation is a biotechnology company that develops a variety of vaccines to prevent and treat cancers and chronic infectious diseases. The company specializes in the development of DNA delivery solutions based on electroporation Its DNA delivery technology increases gene expression and immune responses from DNA vaccines. Inovio Biomedical Corporation s immunotherapy partners include Merck, Wyeth, Vical, the University of Southampton, Moffitt Cancer Center, the National Cancer Institute and International Aids Vaccine Initiative. The company offers pulse generators and handheld applicators to create optimal methods and conditions for facilitating DNA vaccine delivery. Founded in 1983, it develops vaccines for various diseases, such as HIV and hepatitis C.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.